Clinical trial · Observational
Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)
Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators propose to create a database at the regional level, the principle is to include all patients in whom a mutation was detected from a single platform (Lille). The creation of this regional cohort, smaller than the national cohort of Biomarkers France, will perform a more comprehensive collection of clinical data, and molecular monitoring data of patients included. To increase the completeness of the collection of information, it will not be based on voluntary prescribing clinician but will be largely carried out by CRA dedicated to this activity.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Correlation between clinical factors and mutation status
- timeFrame
- at baseline
- description
- The clinical factors are age, smoking status, occupational and environmental exposure, personal and family background, TNM stage, performance status
Secondary outcomes (4)
- measure
- Progression-free survival
- timeFrame
- 3 years
- measure
- Overall survival
- timeFrame
- 3 years
- measure
- Number of patients included in a clinical trial dedicated to a certain type of non-small cell lung cancer with mutation
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged ≥ 18 years old * Patient with non-small cell lung cancer * Detected in the Nord Pas de Calais * Monitored in the Nord Pas de Calais * Patient must have signed a non-opposition form to the use of medical data Exclusion Criteria: \- No identified mutation
References
Publications (0)
Data not yet available